Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine. [PDF]
Children with aggressive neural tumors have poor survival rates and novel therapies are needed. Previous studies have identified nifurtimox and buthionine sulfoximine (BSO) as effective agents in children with neuroblastoma and medulloblastoma.
Du, Michael +4 more
core +1 more source
Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis [PDF]
Despite the fact that eflornithine was considered as the safer drug to treat human African trypanosomiasis (HAT) and has been freely available since 2001, the difficulties in logistics and cost burden associated with this drug meant that the toxic ...
DIARRA, A. +4 more
core
The detection and treatment of human African trypanosomiasis
Bernard Bouteille,1 Alain Buguet21Laboratory of Parasitology, Dupuytren University Hospital of Limoges, France; 2Polyclinic Marie-Louise Poto-Djembo, Pointe-Noire, CongoAbstract: Human African trypanosomiasis (HAT) is caused by the injection of ...
Bouteille B, Buguet A
doaj
Jose R Franco,1 Pere P Simarro,1 Abdoulaye Diarra,2 Jose A Ruiz-Postigo,3 Mireille Samo,1 Jean G Jannin11World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland; 2World Health ...
Franco JR +5 more
doaj
Polyamine Metabolism for Drug Intervention in Trypanosomatids
Neglected tropical diseases transmitted by trypanosomatids include three major human scourges that globally affect the world’s poorest people: African trypanosomiasis or sleeping sickness, American trypanosomiasis or Chagas disease and different types of
Yolanda Pérez-Pertejo +5 more
doaj +1 more source
Effectiveness of a 10-Day Melarsoprol Schedule for the Treatment of Late-Stage Human African Trypanosomiasis: Confirmation from a Multinational Study (Impamel II) [PDF]
BackgroundTreatment of late-stage human African trypanosomiasis (HAT) with melarsoprol can be improved by shortening the regimen. A previous trial demonstrated the safety and efficacy of a 10-day treatment schedule.
Asumu, Pedro N. +10 more
core
Chemoprevention in hereditary digestive neoplasia: A comprehensive review. [PDF]
Chevalier E, Benamouzig R.
europepmc +1 more source
Antileishmanial and Antitrypanosomes Drugs for the Current Century. [PDF]
Alunda JM.
europepmc +1 more source
Combination of Intense Pulsed Light and Topical Eflornithine Therapy Versus Intense Pulsed Light Alone in the Treatment of Idiopathic Facial Hirsutism: A Randomized Controlled Trial. [PDF]
Nawaz MU +5 more
europepmc +1 more source
Poster Awards of the 4th Intercontinental Meeting of Hair Research Societies**Six poster awards, three for clinical and three for experimental hair research, were generously sponsored by Pfizer Consumer Health Care. [PDF]
Tipografía de Noticiero de Vigo
core +1 more source

